Christian Marth, MD, PhD | Authors

SANDOZ

STRMACEDONIA 55

Articles

Is Neoadjuvant Chemotherapy in Ovarian Cancer an Excuse for Insufficient Surgery?

September 13, 2011

Surgical debulking of epithelial ovarian carcinoma has been a mainstay of therapy for more than 50 years-since the approach was first advocated by Meigs in 1934.[1] In 1968, Munnell[2] introduced the idea of the "maximum surgical effort”-essentially the removal of as much cancer as possible.

Use of IP Chemotherapy in Ovarian Cancer: The Critical Questions

February 21, 2011

The article by Dr. Echarri Gonzalez and her colleagues regarding intraperitoneal (IP) chemotherapy for women with epithelial ovarian cancer provides a comprehensive yet practical review of the critical questions surrounding the use of IP chemotherapy.